Week 8: Microbes and industry Flashcards
1917
scientists at Pfizer discovered that Aspergillus niger produces citric acid under
specific environmental conditions
1929
Commercial production began; cheaper and faster product
1940
Pfizer used similar processing technology for large-scale production of
penicillin (Penicillium notatum)
Once identified, most strains used for commercial production require
strain improvement
subjecting stgrain to UV radiation
• Induces random mutations
• Some harmless, some harmful and occasionally one that results in a strain that
overproduces the useful metabolite
• Artificially select and isolate the overproducer and grow this strain
optimizing environmental conditions can also enhance metabolite production:
pH, temp, O2 levels, nutritional factors
primary metabolite production
mirrors cell growth, throughout long phase of growth
secondary metabolite production
occurs after microbial population enters the stationary phase of growth
other important factors of strain selection
- Ability to grow in large-scale cultures
- Rapid growth rate, ideally in inexpensive liquid media
- Safety for humans, animals and the environment (accidental release)
commercial production of antibiotics occurs after
• Shown to be effective against microorganisms in vitro (cells, lab setting) and in vivo
(living animals, lab setting)
• Shown to be safe in animal trials followed by human clinical trials
• Able to be produced large-scale
steroids produced through
bioconversion
bioconversion
microbe converts a common sterol compound into steroid of interest, this is faster adn less expensive than chemical synthesis
proteases
Used to tenderize meat, clean out clogged drains (hair), laundry detergents (blood stain)
cellulases
laundry detergents
extremozymes
derived from microbes living in extreme environments